Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Sterniczuk, Roxanne
Antle, Michael C.
LaFerla, Frank M.
and
Dyck, Richard H.
2010.
Characterization of the 3xTg-AD mouse model of Alzheimer's disease: Part 2. Behavioral and cognitive changes.
Brain Research,
Vol. 1348,
Issue. ,
p.
149.
2010.
Current awareness in geriatric psychiatry.
International Journal of Geriatric Psychiatry,
Vol. 25,
Issue. 12,
Gillette‐Guyonnet, Sophie
Andrieu, Sandrine
Nourhashemi, Fati
Gardette, Virginie
Coley, Nicola
Cantet, Christelle
Gauthier, Serge
Ousset, Pierre‐Jean
and
Vellas, Bruno
2011.
Long‐term progression of Alzheimer's disease in patients under antidementia drugs.
Alzheimer's & Dementia,
Vol. 7,
Issue. 6,
p.
579.
Budson, Andrew E.
and
Solomon, Paul R.
2011.
Memory Loss.
p.
247.
Cravello, Luca
Palmer, Katie
de Girolamo, Giovanni
Caltagirone, Carlo
and
Spalletta, Gianfranco
2011.
Neuropsychiatric symptoms and syndromes in institutionalized elderly people without dementia.
International Psychogeriatrics,
Vol. 23,
Issue. 3,
p.
425.
Spalletta, Gianfranco
Caltagirone, Carlo
Girardi, Paolo
Gianni, Walter
Casini, Anna Rosa
and
Palmer, Katie
2012.
The role of persistent and incident major depression on rate of cognitive deterioration in newly diagnosed Alzheimer's disease patients.
Psychiatry Research,
Vol. 198,
Issue. 2,
p.
263.
Havins, Whitney N.
Massman, Paul J.
and
Doody, Rachelle
2012.
Factor Structure of the Geriatric Depression Scale and Relationships with Cognition and Function in Alzheimer’s Disease.
Dementia and Geriatric Cognitive Disorders,
Vol. 34,
Issue. 5-6,
p.
360.
Herrschaft, Horst
Nacu, Anatol
Likhachev, Sergey
Sholomov, Ilya
Hoerr, Robert
and
Schlaefke, Sandra
2012.
Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: A randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
Journal of Psychiatric Research,
Vol. 46,
Issue. 6,
p.
716.
Stella, Florindo
2013.
Assessment of neuropsychiatric symptoms in dementia: Toward improving accuracy.
Dementia & Neuropsychologia,
Vol. 7,
Issue. 3,
p.
244.
Van der Mussele, Stefan
Le Bastard, Nathalie
Vermeiren, Yannick
Saerens, Jos
Somers, Nore
Mariën, Peter
Goeman, Johan
De Deyn, Peter P.
and
Engelborghs, Sebastiaan
2013.
Behavioral symptoms in mild cognitive impairment as compared with Alzheimer's disease and healthy older adults.
International Journal of Geriatric Psychiatry,
Vol. 28,
Issue. 3,
p.
265.
Beaudreau, Sherry A.
Kaci Fairchild, J.
Spira, Adam P.
Lazzeroni, Laura C.
and
O'Hara, Ruth
2013.
Neuropsychiatric symptoms, apolipoprotein E gene, and risk of progression to cognitive impairment, no dementia and dementia: the Aging, Demographics, and Memory Study (ADAMS).
International Journal of Geriatric Psychiatry,
Vol. 28,
Issue. 7,
p.
672.
Stella, Florindo
de Andrade, Larissa Pires
Garuffi, Marcelo
Vital, Thays Martins
Hernández, Salma Stephany Soleman
Ruocco, Marcela
Sé, Elisandra Villela Gasparetto
Klein, Margarete
Martins, Tânia
and
Robert, Philippe H.
2013.
Validation of the Brazilian version of the Apathy Inventory.
International Journal of Geriatric Psychiatry,
Vol. 28,
Issue. 9,
p.
979.
Lu, Ji-Hui
Zhou, Ai-Hong
Li, Fang
Hao, Zhi-Hui
Li, Wen-Jie
Cui, Zhi-Jie
and
Wang, Wen-Qi
2013.
Risk factors and characteristics of the recurrence of behavioral and psychological symptoms of Alzheimer's disease.
Journal of Clinical Gerontology and Geriatrics,
Vol. 4,
Issue. 4,
p.
115.
Forlenza, Orestes V.
Diniz, Breno S.
Stella, Florindo
Teixeira, Antonio L.
and
Gattaz, Wagner F.
2013.
Mild cognitive impairment (part 1): clinical characteristics and predictors of dementia.
Revista Brasileira de Psiquiatria,
Vol. 35,
Issue. 2,
p.
178.
Stella, Florindo
Forlenza, Orestes Vicente
Laks, Jerson
de Andrade, Larissa Pires
Avendaño, Michelle A. Ljubetic
Sé, Elisandra Villela Gasparetto
Cação, João de Castilho
Lyketsos, Constantine G.
and
de Medeiros, Kate
2013.
The Brazilian version of the Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity in dementia.
International Psychogeriatrics,
Vol. 25,
Issue. 9,
p.
1503.
Yates, Jennifer A
Clare, Linda
and
Woods, Robert T
2013.
Mild cognitive impairment and mood: a systematic review.
Reviews in Clinical Gerontology,
Vol. 23,
Issue. 4,
p.
317.
Gorzoni, Milton Luiz
Fabbri, Renato Moraes Alves
and
Pires, Sueli Luciano
2013.
Senile dementia and pharmacological drugs.
Dementia & Neuropsychologia,
Vol. 7,
Issue. 2,
p.
176.
Bernal-Pacheco, Oscar
and
Fernandez, Hubert H.
2013.
Parkinson’s Disease and Nonmotor Dysfunction.
p.
119.
Desai, Abhilash K.
and
Galliano Desai, Faith
2014.
Management of Behavioral and Psychological Symptoms of Dementia.
Current Geriatrics Reports,
Vol. 3,
Issue. 4,
p.
259.
Armirotti, Andrea
Basit, Abdul
Realini, Natalia
Caltagirone, Carlo
Bossù, Paola
Spalletta, Gianfranco
and
Piomelli, Daniele
2014.
Sample preparation and orthogonal chromatography for broad polarity range plasma metabolomics: Application to human subjects with neurodegenerative dementia.
Analytical Biochemistry,
Vol. 455,
Issue. ,
p.
48.